Global Peripheral Artery Disease Market Report and Forecast 2023-2031

Global Peripheral Artery Disease Market Report and Forecast 2023-2031


Global Peripheral Artery Disease Market Outlook


The global peripheral artery disease market size attained a value of USD 4.42 billion in 2022. The market is anticipated to grow at a CAGR of 6.3% during the forecast period of 2023-2031 to attain a value of USD 7.66 billion by 2031.

Peripheral Artery Disease Market: Introduction


Peripheral artery disease (PAD), also known as peripheral vascular disease (PVD), is a common circulatory problem in which narrowed arteries reduce blood flow to your limbs. The condition is caused by atherosclerosis, a build-up of fatty deposits (plaques) on the inner walls of the arteries. These deposits can reduce or block blood flow through the arteries, leading to PAD. While PAD can affect any arteries outside the heart, it most commonly affects the arteries in the legs.

Risk factors for PAD include:
  • Age: People over the age of 50 are at higher risk.
  • Smoking: Smoking contributes to constriction and damage of the arteries and is a significant risk factor for PAD and other diseases linked to atherosclerosis.
  • Diabetes: People with diabetes have a higher risk of developing PAD due to the increased likelihood of developing atherosclerosis.
  • High blood pressure and high cholesterol: These conditions contribute to the hardening and narrowing of arteries.
  • Obesity: Being overweight adds to the likelihood of developing PAD.
  • Family history: Individuals with a family history of PAD, heart disease, or stroke are at higher risk.
Symptoms of PAD can include cramping pain or tiredness in the leg or hip muscles while walking or climbing stairs, which typically subsides with rest. However, many people with PAD have mild or no symptoms.

PAD can have serious complications, as it increases the risk of coronary artery disease, heart attack, stroke, and mini-strokes or transient ischemic attacks. The reduced blood flow can also lead to tissue death (gangrene) in severe cases.

Early detection and management of PAD is crucial to reduce the risk of heart attack and stroke. It is typically managed with lifestyle changes, medications to prevent blood clots and lower blood pressure and cholesterol, and in some cases, surgical procedures to improve blood flow.

Peripheral Artery Disease Epidemiology


The epidemiology and market division of peripheral artery disease (PAD) are influenced by a variety of factors, including prevalence, age, gender, and lifestyle habits.
  • Prevalence: PAD affects millions of people worldwide, with significant variations in prevalence among different regions. The disease is estimated to affect approximately 200 million people globally, with a higher prevalence in developed countries due to the aging population and high rates of diabetes and obesity.
  • Age: The risk of PAD increases with age. The prevalence of PAD is relatively low in individuals under 50 but begins to rise significantly in those over 60. By age 80, the prevalence can be as high as 20% or more.
  • Gender: Earlier in life, men are more likely than women to develop PAD, although the gap narrows with advancing age. By the age of 70, PAD prevalence rates in women approach those of men.
  • Lifestyle Habits: Certain lifestyle factors significantly influence the risk of developing PAD. Smoking is a strong risk factor, with smokers having up to four times the risk of PAD compared to non-smokers. Unhealthy diet, lack of exercise, and obesity also contribute to PAD risk.
The market for PAD treatment is divided based on these epidemiological factors. The largest market segment is likely to be older adults, given the higher prevalence of PAD with age. Similarly, regions with higher smoking rates and unhealthy lifestyle habits might represent larger market segments.

In terms of gender, while the market is likely more significant in men due to their slightly higher prevalence rates, the market for women is also substantial, especially in older age groups.

In terms of lifestyle habits, the market for PAD treatments is likely larger among smokers and individuals with unhealthy lifestyles, given their increased risk.

Overall, the PAD market is influenced by a variety of factors, with age, smoking, and unhealthy lifestyle habits being key drivers. As the global population ages and the prevalence of risk factors like smoking and obesity continues to rise, the market for PAD treatments is likely to grow

Peripheral Artery Disease Market Segmentations


The market can be categorised into type, treatment, distribution channel, end user, and region.

Peripheral Artery Market Breakup by Type
  • Peripheral Angioplasty Balloons
1. Old/Normal Balloons

2. Cutting and Scoring Balloons

3. Drug-Coated Balloons
  • Peripheral Stents
1. Self-Expandable

2. Balloon-Expandable

3. Covered Stents

4. Drug-Eluting Stents
  • Peripheral Catheters
1. Angiography Catheters

2. Guiding Catheters
  • Inferior Vena Cava (IVC) Filters
1. Permanent Filters

2. Retrievable Filters
  • Plaque Modification Devices
1. Thrombectomy Devices

2. Atherectomy Devices
  • Haemodynamic Flow Alteration Devices
1. Embolic Protection Devices

2. Chronic Total Occlusion Devices
  • Peripheral Accessories
1. Peripheral Vascular Closure Devices

2. Introducer Sheaths

3. Guidewires

4. Balloon Inflation Devices

Peripheral Artery Disease Market Breakup by Treatment
  • Oral
  • Parenteral
  • Others
Market Breakup by Distribution channel
  • Hospital Pharmacy
  • Retail Pharmacy
  • Others
Market Breakup by End user
  • Hospitals
  • Specialty Clinics
  • Others
Peripheral Artery Disease Market Breakup by Region
  • North America
  • United States of America
  • Canada
  • Europe
  • United Kingdom
  • Germany
  • France
  • Italy
  • Others
  • Asia Pacific
  • China
  • Japan
  • India
  • ASEAN
  • Australia
  • Others
  • Latin America
  • Brazil
  • Argentina
  • Mexico
  • Others
  • Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Nigeria
  • South Africa
  • Others

Peripheral Artery Disease Market Scenario

  • The global market for peripheral artery disease (PAD) is expected to see robust growth in the coming years. This can be attributed to several factors, including an aging global population, increasing prevalence of lifestyle diseases like diabetes and obesity, and heightened awareness of PAD and its complications.
  • With PAD affecting a substantial number of people worldwide, there is a strong demand for effective treatments. The market comprises of various treatment options including medications, angioplasty and stenting, bypass surgery, and thrombolytic therapy. Among these, the angioplasty segment holds a significant market share due to its minimally invasive nature and high success rate.
  • Geographically, North America currently dominates the PAD market, owing to factors such as a high prevalence of PAD, advanced healthcare infrastructure, and high healthcare expenditure. However, the Asia-Pacific region is expected to witness the fastest growth rate during the forecast period. This can be attributed to factors such as a rapidly aging population, increasing incidence of diabetes and obesity, improving healthcare infrastructure, and growing awareness of PAD.
  • There is also a growing trend towards the development of innovative and more effective treatment options for PAD. Pharmaceutical and medical device companies are investing heavily in research and development activities to create novel therapies, with a number of these therapies currently in clinical trials. This innovation-driven growth is expected to contribute significantly to the expansion of the PAD market.
  • However, the PAD market faces certain challenges. These include the high cost of treatment procedures and lack of awareness about PAD in some regions, which may limit the diagnosis and treatment of the disease. Additionally, the risk of complications associated with treatment procedures may also restrain market growth.
In conclusion, while the global PAD market is set to experience significant growth, driven by factors such as an aging population, increasing prevalence of lifestyle diseases, and innovations in treatment options, market players will need to address challenges such as high treatment costs and lack of awareness to fully capitalize on these growth opportunities.

Key Players in the Global Peripheral Artery Disease Market


The report gives an in-depth analysis of the key players involved in the peripheral artery disease market, sponsors manufacturing the drugs, and putting them through trials to get FDA approvals. The companies included in the market are as follows:
  • AngioDynamics Inc.
  • B. Braun Melsungen AG
  • Biotronik Inc.
  • Boston Scientific Corp.
  • Cook Group Incorporated
  • Terumo Corporation
  • Koninklijke Philips N.V.
  • Becton, Dickinson and Company
  • W. L. Gore & Associates, Inc.
  • LeMaitre Vascular, Inc.
*Please Note:* The report will be completed in 7 business days after order confirmation


1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Peripheral Artery Disease Overview
3.1 Guidelines and Stages
3.2 Pathophysiology
3.3 Screening and Diagnosis
3.4 Treatment Pathway
4 Patient Profile
4.1 Patient Profile Overview
4.2 Patient Psychology and Emotional Impact Factors
4.3 Risk Assessment and Treatment Success Rate
5 Peripheral Artery Disease Epidemiology Analysis
5.1 Epidemiology Overview (2016-2031)
5.2 North America Peripheral Artery Disease Epidemiology (2016-2031)
5.3 Europe Peripheral Artery Disease Epidemiology (2016-2031)
5.4 Asia-Pacific Peripheral Artery Disease Epidemiology (2016-2031)
5.5 Latin America Peripheral Artery Disease Epidemiology (2016-2031)
5.6 Middle East & Africa Peripheral Artery Disease Epidemiology (2016-2031)
6 Global Peripheral Artery Disease Market Overview
6.1 Global Peripheral Artery Disease Market Historical Value (2016-2022)
6.2 Global Peripheral Artery Disease Market Forecast Value (2023-2031)
7 Global Peripheral Artery Disease Market Landscape
7.1 Peripheral Artery Disease: Developers Landscape
7.1.1 Analysis by Year of Establishment
7.1.2 Analysis by Company Size
7.1.3 Analysis by Region
7.2 Peripheral Artery Disease: Product Landscape
7.2.1 Analysis by Type
7.2.2 Analysis by Treatment
7.2.3 Analysis by Distribution Channel
7.2.4 Analysis by End User
8 Peripheral Artery Disease Challenges and Unmet Needs
8.1 Treatment Pathway Challenges
8.2 Compliance and Drop-Out Analysis
8.3 Awareness and Prevention Gaps
9 Cost of Treatment
10 Global Peripheral Artery Disease Market Dynamics
10.1 Market Drivers and Constraints
10.2 SWOT Analysis
10.3 Porter’s Five Forces Model
10.4 Key Demand Indicators
10.5 Key Price Indicators
10.6 Industry Events, Initiatives, and Trends
10.7 Value Chain Analysis
11 Global Peripheral Artery Disease Market Segmentation
11.1 Global Peripheral Artery Disease Market by Type
11.1.1 Market Overview
11.1.2 Peripheral Angioplasty Balloons
11.1.2.1 Old/Normal Balloons
11.1.2.2 Cutting and Scoring Balloons
11.1.2.3 Drug-Coated Balloons
11.1.3 Peripheral Stents
11.1.3.1 Self-Expandable
11.1.3.2 Balloon-Expandable
11.1.3.3 Covered Stents
11.1.3.4 Drug-Eluting Stents
11.1.4 Peripheral Catheters
11.1.4.1 Angiography Catheters
11.1.4.2 Guiding Catheters
11.1.5 Inferior Vena Cava (IVC) Filters
11.1.5.1 Permanent Filters
11.1.5.2 Retrievable Filters
11.1.6 Plaque Modification Devices
11.1.6.1 Thrombectomy Devices
11.1.6.2 Atherectomy Devices
11.1.7 Haemodynamic Flow Alteration Devices
11.1.7.1 Embolic Protection Devices
11.1.7.2 Chronic Total Occlusion Devices
11.1.8 Peripheral Accessories
11.1.8.1 Peripheral Vascular Closure Devices
11.1.8.2 Introducer Sheaths
11.1.8.3 Guidewires
11.1.8.4 Balloon Inflation Devices
11.2 Global Peripheral Artery Disease Market by Treatment
11.2.1 Market Overview
11.2.2 Oral
11.2.3 Parenteral
11.2.4 Others
11.3 Global Peripheral Artery Disease Market by Distribution Channel
11.3.1 Market Overview
11.3.2 Hospital Pharmacy
11.3.3 Retail Pharmacy
11.3.4 Others
11.4 Global Peripheral Artery Disease Market by End User
11.4.1 Market Overview
11.4.2 Hospitals
11.4.3 Specialty Clinics
11.4.4 Others
11.5 Global Peripheral Artery Disease Market by Region
11.5.1 Market Overview
11.5.2 North America
11.5.3 Europe
11.5.4 Asia Pacific
11.5.5 Latin America
11.5.6 Middle East and Africa
12 North America Peripheral Artery Disease Market
12.1 Market Share by Country
12.2 United States of America
12.3 Canada
13 Europe Peripheral Artery Disease Market
13.1 Market Share by Country
13.2 United Kingdom
13.3 Germany
13.4 France
13.5 Italy
13.6 Others
14 Asia Pacific Peripheral Artery Disease Market
14.1 Market Share by Country
14.2 China
14.3 Japan
14.4 India
14.5 ASEAN
14.6 Australia
14.7 Others
15 Latin America Peripheral Artery Disease Market
15.1 Market Share by Country
15.2 Brazil
15.3 Argentina
15.4 Mexico
15.5 Others
16 Middle East and Africa Peripheral Artery Disease Market
16.1 Market Share by Country
16.2 Saudi Arabia
16.3 United Arab Emirates
16.4 Nigeria
16.5 South Africa
16.6 Others
17 Regulatory Framework
17.1 Regulatory Overview
17.1.1 US FDA
17.1.2 EU EMA
17.1.3 INDIA CDSCO
17.1.4 JAPAN PMDA
17.1.5 Others
18 Patent Analysis
18.1 Analysis by Type of Patent
18.2 Analysis by Publication year
18.3 Analysis by Issuing Authority
18.4 Analysis by Patent Age
18.5 Analysis by CPC Analysis
18.6 Analysis by Patent Valuation
18.7 Analysis by Key Players
19 Grants Analysis
19.1 Analysis by year
19.2 Analysis by Amount Awarded
19.3 Analysis by Issuing Authority
19.4 Analysis by Grant Application
19.5 Analysis by Funding Institute
19.6 Analysis by NIH Departments
19.7 Analysis by Recipient Organization
20 Clinical Trials Analysis
20.1 Analysis by Trial Registration Year
20.2 Analysis by Trial Status
20.3 Analysis by Trial Phase
20.4 Analysis by Therapeutic Area
20.5 Analysis by Geography
21 Funding and Investment Analysis
21.1 Analysis by Funding Instances
21.2 Analysis by Type of Funding
21.3 Analysis by Funding Amount
21.4 Analysis by Leading Players
21.5 Analysis by Leading Investors
21.6 Analysis by Geography
22 Partnership and Collaborations Analysis
22.1 Analysis by Partnership Instances
22.2 Analysis by Type of Partnership
22.3 Analysis by Leading Players
22.4 Analysis by Geography
23 Supplier Landscape
23.1 AngioDynamics Inc.
23.1.1 Financial Analysis
23.1.2 Product Portfolio
23.1.3 Demographic Reach and Achievements
23.1.4 Mergers and Acquisitions
23.1.5 Certifications
23.2 B. Braun Melsungen AG
23.2.1 Financial Analysis
23.2.2 Product Portfolio
23.2.3 Demographic Reach and Achievements
23.2.4 Mergers and Acquisitions
23.2.5 Certifications
23.3 Biotronik Inc.
23.3.1 Financial Analysis
23.3.2 Product Portfolio
23.3.3 Demographic Reach and Achievements
23.3.4 Mergers and Acquisitions
23.3.5 Certifications
23.4 Boston Scientific Corp.
23.4.1 Financial Analysis
23.4.2 Product Portfolio
23.4.3 Demographic Reach and Achievements
23.4.4 Mergers and Acquisitions
23.4.5 Certifications
23.5 Cook Group Incorporated
23.5.1 Financial Analysis
23.5.2 Product Portfolio
23.5.3 Demographic Reach and Achievements
23.5.4 Mergers and Acquisitions
23.5.5 Certifications
23.6 Terumo Corporation
23.6.1 Financial Analysis
23.6.2 Product Portfolio
23.6.3 Demographic Reach and Achievements
23.6.4 Mergers and Acquisitions
23.6.5 Certifications
23.7 Koninklijke Philips N.V.
23.7.1 Financial Analysis
23.7.2 Product Portfolio
23.7.3 Demographic Reach and Achievements
23.7.4 Mergers and Acquisitions
23.7.5 Certifications
23.8 Becton, Dickinson and Company
23.8.1 Financial Analysis
23.8.2 Product Portfolio
23.8.3 Demographic Reach and Achievements
23.8.4 Mergers and Acquisitions
23.8.5 Certifications
23.9 W. L. Gore & Associates, Inc.
23.9.1 Financial Analysis
23.9.2 Product Portfolio
23.9.3 Demographic Reach and Achievements
23.9.4 Mergers and Acquisitions
23.9.5 Certifications
23.10 LeMaitre Vascular, Inc.
23.10.1 Financial Analysis
23.10.2 Product Portfolio
23.10.3 Demographic Reach and Achievements
23.10.4 Mergers and Acquisitions
23.10.5 Certifications
24 Peripheral Artery Disease - Distribution Model (Additional Insight)
24.1 Overview
24.2 Potential Distributors
24.3 Key Parameters for Distribution Partner Assessment
25 Key Opinion Leaders (KOL) Insights (Additional Insight)
26 Company Competitiveness Analysis (Additional Insight)
26.1 Very Small Companies
26.2 Small Companies
26.3 Mid-Sized Companies
26.4 Large Companies
26.5 Very Large Companies
27 Payment Methods (Additional Insight)
27.1 Government Funded
27.2 Private Insurance
27.3 Out-of-Pocket

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings